Shares of InterCure Ltd. (NASDAQ:INCR – Get Free Report) dropped 3.4% during trading on Monday . The stock traded as low as $1.43 and last traded at $1.44. Approximately 37,166 shares traded hands during trading, a decline of 6% from the average daily volume of 39,383 shares. The stock had previously closed at $1.49.
InterCure Stock Performance
The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.15 and a current ratio of 1.78. The business’s 50-day moving average is $1.63 and its 200 day moving average is $1.63.
Institutional Investors Weigh In On InterCure
Several hedge funds have recently modified their holdings of the company. Virtu Financial LLC acquired a new stake in shares of InterCure during the third quarter worth $43,000. Jane Street Group LLC acquired a new stake in InterCure in the third quarter valued at approximately $49,000. Finally, Moore Capital Management LP bought a new stake in InterCure during the 4th quarter valued at $156,000. Institutional investors and hedge funds own 8.34% of the company’s stock.
InterCure Company Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Recommended Stories
- Five stocks we like better than InterCure
- The Significance of Brokerage Rankings in Stock Selection
- Energy Transfer: Powering Data With Dividends and Diversification
- EV Stocks and How to Profit from Them
- Qualcomm Stock Is Coiling for a Breakout
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
